Skip to main content

CITADEL ADVISORS LLC

Position in AURA — Aura Biosciences, Inc.

CIK 1423053 MIAMI, FL

Position in AURA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$83,644
-$289,948 QoQ
Shares Held
12,503
-81.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Derivatives in AURA

reported options exposure · as of Mar 31, 2025
CallValue
$35,160
CallShares
6,000
PutValue
$37,504
PutShares
6,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names. AURA ranks #329 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AURA

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $83,644 12,503
2025-12-31 $373,592 68,549
2025-06-30 $80,322 12,831
2025-03-31 $961,279 164,041
2025-03-31 $37,504 6,400
2025-03-31 $35,160 6,000
2024-12-31 $63,935 7,778
2024-12-31 $55,074 6,700
2024-12-31 $15,618 1,900
2024-09-30 $41,877 4,700
2024-09-30 $281,556 31,600
2024-09-30 $9,008 1,011
2024-06-30 $13,608 1,800
2024-06-30 $6,048 800
2024-06-30 $17,680,306 2,338,665
2024-03-31 $11,775 1,500
2024-03-31 $28,858,735 3,676,272
2024-03-31 $3,140 400
2023-12-31 $32,173,264 3,631,294
2023-12-31 $18,606 2,100
2023-12-31 $1,772 200
2023-09-30 $22,282,080 2,484,067
2023-09-30 $8,970 1,000
2023-06-30 $12,350 1,000
2023-06-30 $30,388,174 2,460,581
2023-06-30 $12,350 1,000
2023-03-31 $23,220,610 2,502,221
2022-12-31 $28,739,056 2,737,053
2022-09-30 $41,899,201 2,312,318
2022-06-30 $32,763,292 2,312,159
2022-03-31 $50,966,366 2,316,653
2021-12-31 $39,310,431 2,315,102